Similar articles

• Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.

  Shelton RJ, Goode K, Cleland JG. Shelton RJ, et al. Europace. 2007 Feb;9(2):147; author reply 148. doi: 10.1093/europace/eul147. Epub 2007 Jan 16. Europace. 2007. PMID: 17227813 No abstract available.
• Diagnosis of heart failure using urinary natriuretic peptides.

  Ng LL, Geeranavar S, Jennings SC, Loke I, O'Brien RJ. Ng LL, et al. Clin Sci (Lond). 2004 Feb;106(2):129-33. doi: 10.1042/CS20030234. Clin Sci (Lond). 2004. PMID: 13678415
• Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.

  van Kimmenade RR, Pinto YM, Bayes-Genis A, Lainchbury JG, Richards AM, Januzzi JL Jr. van Kimmenade RR, et al. Am J Cardiol. 2006 Aug 1;98(3):386-90. doi: 10.1016/j.amjcard.2006.02.043. Epub 2006 Jun 12. Am J Cardiol. 2006. PMID: 16860029
• [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].

  Dahlström U, Alehagen U. Dahlström U, et al. Lakartidningen. 2006 Mar 22-28;103(12):927-9. Lakartidningen. 2006. PMID: 16618036 Review. Swedish. No abstract available.
• Prospects for using a blood sample in the diagnosis of heart failure.

  Struthers AD. Struthers AD. QJM. 1995 May;88(5):303-6. QJM. 1995. PMID: 7796082 Review. No abstract available.